450 related articles for article (PubMed ID: 31671790)
1. Role of Hypoxia and Metabolism in the Development of Neointimal Hyperplasia in Arteriovenous Fistulas.
Sadaghianloo N; Contenti J; Dardik A; Mazure NM
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671790
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia and hypoxia-inducible factors promote the development of neointimal hyperplasia in arteriovenous fistula.
Sadaghianloo N; Contenti J; Declemy S; Ambrosetti D; Zdralevic M; Tannour-Louet M; Fabbri L; Pagès G; Bost F; Hassen-Khodja R; Pouysségur J; Jean-Baptiste E; Dardik A; Mazure NM
J Physiol; 2021 Apr; 599(8):2299-2321. PubMed ID: 33608879
[TBL] [Abstract][Full Text] [Related]
3. Vascularization of the arteriovenous fistula wall and association with maturation outcomes.
Duque JC; Martinez L; Tabbara M; Parikh P; Paez A; Selman G; Salman LH; Velazquez OC; Vazquez-Padron RI
J Vasc Access; 2020 Mar; 21(2):161-168. PubMed ID: 31608758
[TBL] [Abstract][Full Text] [Related]
4. New Developments in Our Understanding of Neointimal Hyperplasia.
Lee T; Ul Haq N
Adv Chronic Kidney Dis; 2015 Nov; 22(6):431-7. PubMed ID: 26524947
[TBL] [Abstract][Full Text] [Related]
5. In vivo nanoparticle assessment of pathological endothelium predicts the development of inflow stenosis in murine arteriovenous fistula.
Cui J; Kessinger CW; McCarthy JR; Sosnovik DE; Libby P; Thadhani RI; Jaffer FA
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):189-96. PubMed ID: 25395614
[TBL] [Abstract][Full Text] [Related]
6. Hyperbaric oxygen inhibits venous neointimal hyperplasia following arteriovenous fistulization.
Li Z; Li M; Li X; Zhang M; Zhao Y; Ren W; Cheng J; Wang X
Int J Mol Med; 2017 May; 39(5):1299-1306. PubMed ID: 28393184
[TBL] [Abstract][Full Text] [Related]
7. Severe Endothelial Damage in Chronic Kidney Disease Patients Prior to Haemodialysis Vascular Access Surgery.
Pushevski V; Dejanov P; Gerasimovska V; Petrushevska G; Oncevski A; Sikole A; Popov Z; Ivanovski N
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(3):43-9. PubMed ID: 27442395
[TBL] [Abstract][Full Text] [Related]
8. Histopathology of Veins Obtained at Hemodialysis Arteriovenous Fistula Creation Surgery.
Alpers CE; Imrey PB; Hudkins KL; Wietecha TA; Radeva M; Allon M; Cheung AK; Dember LM; Roy-Chaudhury P; Shiu YT; Terry CM; Farber A; Beck GJ; Feldman HI; Kusek JW; Himmelfarb J;
J Am Soc Nephrol; 2017 Oct; 28(10):3076-3088. PubMed ID: 28724774
[TBL] [Abstract][Full Text] [Related]
9. Localized Perivascular Therapeutic Approaches to Inhibit Venous Neointimal Hyperplasia in Arteriovenous Fistula Access for Hemodialysis Use.
Barcena AJR; Perez JVD; Liu O; Mu A; Heralde FM; Huang SY; Melancon MP
Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291576
[TBL] [Abstract][Full Text] [Related]
10. One-year patency rate of native arteriovenous fistulas reconstructed by vascular stripping in hemodialysis patients with venous neointimal hyperplasia.
Lu FP; Liu LP; Lu ZX
J Vasc Surg; 2015 Jan; 61(1):192-6. PubMed ID: 25135873
[TBL] [Abstract][Full Text] [Related]
11. Disturbed flow in the juxta-anastomotic area of an arteriovenous fistula correlates with endothelial loss, acute thrombus formation, and neointimal hyperplasia.
Bai H; Varsanik MA; Thaxton C; Ohashi Y; Gonzalez L; Zhang W; Aoyagi Y; Kano M; Yatsula B; Li Z; Pocivavsek L; Dardik A
Am J Physiol Heart Circ Physiol; 2024 Jun; 326(6):H1446-H1461. PubMed ID: 38578237
[TBL] [Abstract][Full Text] [Related]
12. Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis.
Lee T; Roy-Chaudhury P
Adv Chronic Kidney Dis; 2009 Sep; 16(5):329-38. PubMed ID: 19695501
[TBL] [Abstract][Full Text] [Related]
13. The Role of MicroRNA-21 in Venous Neointimal Hyperplasia: Implications for Targeting miR-21 for VNH Treatment.
Kilari S; Cai C; Zhao C; Sharma A; Chernogubova E; Simeon M; Wu CC; Song HL; Maegdefessel L; Misra S
Mol Ther; 2019 Sep; 27(9):1681-1693. PubMed ID: 31326400
[TBL] [Abstract][Full Text] [Related]
14. Transitional Flow in the Venous Side of Patient-Specific Arteriovenous Fistulae for Hemodialysis.
Bozzetto M; Ene-Iordache B; Remuzzi A
Ann Biomed Eng; 2016 Aug; 44(8):2388-2401. PubMed ID: 26698581
[TBL] [Abstract][Full Text] [Related]
15. Restoration of autologous arteriovenous fistula by vascular stripping in a hemodialysis patient with venous neointimal hyperplasia.
Lu FP; Lu ZX; Liu X; Liu LP
J Vasc Access; 2012; 13(4):524-6. PubMed ID: 22865536
[TBL] [Abstract][Full Text] [Related]
16. Adventitial transduction of lentivirus-shRNA-VEGF-A in arteriovenous fistula reduces venous stenosis formation.
Yang B; Janardhanan R; Vohra P; Greene EL; Bhattacharya S; Withers S; Roy B; Nieves Torres EC; Mandrekar J; Leof EB; Mukhopadhyay D; Misra S
Kidney Int; 2014 Feb; 85(2):289-306. PubMed ID: 23924957
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamics in AVF over time: A protective role of vascular remodeling toward flow stabilization.
Soliveri L; Bozzetto M; Brambilla P; Caroli A; Remuzzi A
Int J Artif Organs; 2023; 46(10-11):547-554. PubMed ID: 37753863
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin mediation of disturbed flow-induced endothelial mesenchymal transition through CD44 is a novel mechanism of neointimal hyperplasia in arteriovenous fistulae for hemodialysis access.
Chang CJ; Lai YJ; Tung YC; Wu LS; Hsu LA; Tseng CN; Chang GJ; Yang KC; Yeh YH
Kidney Int; 2023 Apr; 103(4):702-718. PubMed ID: 36646166
[TBL] [Abstract][Full Text] [Related]
19. Rationale and Trial Design of MesEnchymal Stem Cell Trial in Preventing Venous Stenosis of Hemodialysis Vascular Access Arteriovenous Fistula (MEST AVF Trial).
Piryani AK; Kilari S; Takahashi E; DeMartino RR; Mandrekar J; Dietz AB; Misra S
Kidney360; 2021 Dec; 2(12):1945-1952. PubMed ID: 35419530
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-21 and Venous Neointimal Hyperplasia of Dialysis Vascular Access.
Wu CC; Chen LJ; Hsieh MY; Lo CM; Lin MH; Tsai HE; Song HL; Chiu JJ
Clin J Am Soc Nephrol; 2018 Nov; 13(11):1712-1720. PubMed ID: 30242025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
